Design Therapeutics, Inc. (DSGN)
10.56
+0.10
(+0.91%)
USD |
NASDAQ |
Jun 09, 16:00
10.56
0.00 (0.00%)
After-Hours: 19:03
Design Therapeutics EPS Diluted (Quarterly) : -0.2871 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Precigen, Inc. | -0.0224 |
| Agenus, Inc. | 1.023 |
| Amgen, Inc. | 3.344 |
| BioCryst Pharmaceuticals, Inc. | -2.980 |
| Imunon, Inc. | -0.8449 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.64M |
| Total Expenses (Quarterly) | 17.64M |
| Enterprise Value | 433.05M |
| Earnings Yield | -11.31% |
| Normalized Earnings Yield | -11.31 |